You are here
23.1 Basic principles
The underlying principles for the approval of pharmaceutical treatment for SRCA clients are that the medications:
- be necessary to improve any conditions for which the client has accepted liability.
- do no harm.
- be of a reasonable cost (considering the cost of treatment against the expected gains).
- be clinically effective (considering the available evidence).
- be accepted clinical practice (considering the current professional opinion).
- The treating doctor or specialist should initiate requests for all medication and prescribe or ourlint medications in a treatment plan.
- Clients seeking pharmaceutical approval should be directed to ask their treating practitioner to contact DVA or VAPAC.
- The medications prescribed should be directly related to the client's existing liabilities.
- Is it apparent how the medication will benefit the client? What are the expected outcomes of treatment?
- VAPAC should be contacted to advise when considering requests for non PBS items?
- Are the cost, quantity and dose reasonable? VAPAC can advise on this.
- Has the client received similar medications recently and if so, do the current requests reflect safe dispensing practices, and is it apparent why repeat medications are necessary?
- Has a similar request for medication been declined in the past? If so, why does it need to be prescribed again? VAPAC can advise on this.
- Do delegates have enough information from all relevant parties to make an informed decision?